#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Medullary thyroid cancer Chronic graft versus host disease in intestine Alternating hemiplegia of childhood Arterial disorder B precursor type acute leukaemia Oesophageal atresia Familial haemophagocytic lymphohistiocytosis Liposarcoma recurrent Acute graft versus host disease Ovarian cancer Acute promyelocytic leukaemia Leiomyosarcoma metastatic Hereditary spastic paraplegia Colitis ulcerative Small cell lung cancer recurrent More trials…

    Learn about Rare Diseases

    Antithrombin III deficiency – Life with Disease Bronchiolitis obliterans syndrome Indolent systemic mastocytosis Castleman’s disease – Basic Information MELAS syndrome – Trials in Disease Rhabdomyosarcoma Biotinidase deficiency – Life with Disease Mantle cell lymphoma stage III – Diagnostics Phenylketonuria – Diagnostics Adrenogenital syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AMLENETUG Enpatoran Obexelimab Kd050 Lasn01 THEOPHYLLINE ANHYDROUS Mitoxantrone Asp1570 Tasimelteon Axicabtagene Ciloleucel Navtemadlin Remibrutinib Vildagliptin Carbamazepine Enzalutamide LY3537031 Disodium Folinate Pramlintide Acetate Osilodrostat Macitentan More therapies…

    Learn about Your Condition

    Lipid metabolism disorder Overweight Aicardi-Goutieres syndrome Mastocytosis Pulmonary hypertension Aplasia pure red cell Asymptomatic HIV infection Iron deficiency Poor quality sleep Neuralgia Breast cancer male Leiomyosarcoma recurrent Retinopathy of prematurity Portal hypertension Arteriosclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colon cancer stage III

  • Study on Atezolizumab for Patients with High-Risk Stage II or Stage III Colorectal Cancer Not Eligible for Oxaliplatin Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    • Colon cancer stage III
    • Colorectal adenocarcinoma
    Investigated Drugs:
    • Mycobaterium Obuense, Strain Nctc 13365, Heat-Killed
    • Atezolizumab
    Germany

  • Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Stage II and III Colon Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Colon cancer stage III
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Placebo
    The Netherlands

  • Study on Aspirin for Preventing Recurrence and Improving Survival in Patients with Resected Colon Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Placebo
    Belgium

  • Study on High-Dose Vitamin C with Ipilimumab and Nivolumab for Patients with Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Colon cancer stage IV
    • Colon cancer
    Investigated Drugs:
    • Ascorbic Acid
    • Ipilimumab
    • Nivolumab
    Italy
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!